Dapagliflozin
H1407-176-598
Unknown small_molecule completed
Quick answer
Dapagliflozin for Diabetes Mellitus, Type 2 is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed